Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Plos One|January 4, 2013
Roles for NHERF1 and NHERF2 on the regulation of C3a receptor signaling in human mast cellsHariharan Subramanian, Kshitij Gupta, Hydar AliInnate Immunity|October 30, 2015
Modulation of host defense peptide-mediated human mast cell activation by LPSKshitij Gupta, Hariharan Subramanian, Hydar AliImmunology and Allergy Clinics of North America|April 26, 2022
Mas-Related G Protein-Coupled Receptor-X2 and Its Role in Non-immunoglobulin E-Mediated Drug HypersensitivityChalatip Chompunud Na Ayudhya, Hydar AliFrontiers in Immunology|January 3, 2025
The development of murine bone marrow-derived mast cells expressing functional human MRGPRX2 for <i>ex vivo</i> and <i>in vivo</i> studiesMaram Bawazir, Saptarshi Roy, Hydar AliJournal of Immunology (Baltimore, Md. : 1950)|May 26, 2018
Naturally Occurring Missense MRGPRX2 Variants Display Loss of Function Phenotype for Mast Cell Degranulation in Response to Substance P, Hemokinin-1, Human β-Defensin-3, and IcatibantIbrahim Alkanfari, Kshitij Gupta, Tahsin Jahan, et al.Plos One|July 30, 2011
Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinasesQiang Guo, Hariharan Subramanian, Kshitij Gupta, et al.Plos One|October 19, 2012
Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cellsKshitij Gupta, Hariharan Subramanian, Andreas Klos, et al.International Journal of Molecular Sciences|June 2, 2021
Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor InternalizationChalatip Chompunud Na Ayudhya, Aetas Amponnawarat, Hydar AliJournal of Immunology (Baltimore, Md. : 1950)|January 18, 2019
Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B<sub>2</sub> Receptor Antagonist Icatibant Are G Protein Biased Agonists for MRGPRX2 in Mast CellsSaptarshi Roy, Anirban Ganguly, Maureen Haque, et al.Current Pharmaceutical Design|November 23, 2011
PIP3 regulation as promising targeted therapy of mast-cell-mediated diseasesBruce J Shenker, Hydar Ali, Kathleen Boesze-BattagliaPageof 6